Pressmeddelanden från Lifecare

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

LIFE: Lifecare ASA Q4 2025 results

Bergen, Norway, 3 March 2026 - Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucos...

MFN • Idag 07:00

Lifecare ASA: Commencement of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • Igår 07:00

Lifecare ASA: Exercise price for Warrants Series 1 issued in connection with the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 27 feb 19:06

Lifecare reaches regulatory milestone - veterinary product cleared for sales in Europe

Bergen, Norway, 26 February 2026 – Lifecare ASA (LIFE), a MedTech company developing next-generation implantable Continuous Glucose Monitori...

MFN • 26 feb 07:00

Lifecare ASA appoints Petter Nielsen as Chief Financial Officer

Bergen, Norway, 25 February 2026 – Lifecare ASA (LIFE), a MedTech company developing next-generation implantable continuous glucose monitori...

MFN • 25 feb 07:00

Lifecare ASA (LIFE): Invitation to Q4 2025 results presentation

Lifecare ASA will release its Q4 2025 results on Tuesday, 3 March 2026 at 07:00 CET.

MFN • 24 feb 14:30

Lifecare signs EU Declaration of Conformity for implant electronics

Bergen, Norway, 23 February 2026 – Lifecare ASA (LIFE), a MedTech company developing next-generation implantable Continuous Glucose Monitori...

MFN • 23 feb 07:00

Lifecare receives notification of intended grant in European patent application and provides update on IP strategy

Bergen, Norway, 19 February 2026 - Lifecare ASA (LIFE), a MedTech company developing next-generation implantable continuous glucose monitori...

MFN • 19 feb 07:00

Lifecare completes production-level compliance testing of implant electronics - moves to finalize CE claim

Bergen, Norway, 17 February 2026 - Lifecare ASA (LIFE), a MedTech company developing next-generation implantable Continuous Glucose Monitori...

MFN • 17 feb 07:00

Lifecare submits updated documentation to NoMA: regulatory review resumes in first-in-human study application

Bergen, Norway 5 February 2026 - Lifecare ASA (LIFE), a MedTech company developing next-generation Continuous Glucose Monitoring (CGM) techn...

MFN • 05 feb 07:56

Lifecare ASA: Share capital increase and warrants registered

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 29 January 2026 regarding the board of dir...

MFN • 03 feb 09:02

PFU rules that Finansavisen breached press ethics in coverage of Lifecare’s market disclosures

Bergen, 30 January 2026 - Lifecare ASA notes that the Norwegian Press Complaints Commission (PFU) has upheld the Company’s complaint concern...

MFN • 30 jan 07:00

Lifecare ASA: Information about the warrants issued in connection with the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 30 jan 07:00

Lifecare ASA: Mandatory notification of trade

MFN • 29 jan 17:04

Lifecare ASA: Mandatory notification of trade - allocation of Underwriting Commission Shares and Warrants

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 22 January 2026 and previous announcements...

MFN • 29 jan 14:45

Lifecare ASA: Mandatory notification of trade - allocation of Underwriting Commission Shares and Warrants

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 22 January 2026 and previous announcements...

MFN • 29 jan 14:45

Lifecare ASA: Resolution to issue underwriting commission shares

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 22 January 2026 and previous announcements...

MFN • 29 jan 13:55

Lifecare ASA: Share capital increase and warrants registered

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 22 January 2026 regarding the final result...

MFN • 28 jan 17:29

Lifecare ASA: Mandatory notification of trade

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") on 22 January 2026 regarding the final results of the r...

MFN • 23 jan 14:55

Lifecare ASA: Final results of the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 22 jan 10:40

Lifecare ASA: Mandatory notification of trade – subscription of shares in rights issue

Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 7 January 2026 regarding the commencement ...

MFN • 22 jan 10:12

Lifecare ASA: Preliminary results of the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 21 jan 20:16

Lifecare ASA: Last day of the subscription period for the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 21 jan 07:00

Lifecare highlights real-world veterinary relevance from ongoing diabetes study

Bergen, Norway, 19 January 2026 - Lifecare ASA (LIFE) today shares early real-world experience from its ongoing study LFC-SEN-002, illustrat...

MFN • 19 jan 07:00

Lifecare ASA: Last day of trading in Subscription Rights

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 15 jan 07:00

Lifecare ASA: Mandatory notification of trade – subscription of shares in rights issue

Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 7 January 2026 regarding the commencement ...

MFN • 14 jan 14:05

Lifecare’s implant continues to track glucose where traditional CGMs reach their limits

Bergen, Norway, 13 January 2026 - Lifecare ASA (LIFE) today reports new findings from its ongoing longevity study LFC-SEN-002, showing that ...

MFN • 13 jan 07:00

Lifecare ASA (LIFE): Invitation to webcast presentation on 13 January 2026 at 11:30 CET

The CEO of Lifecare ASA, Joacim Holter, will hold a webcast presentation providing a general update on Lifecare’s current status and ongoing...

MFN • 12 jan 11:00

Lifecare confirms reproducible implant tracks glucose in vivo

Bergen, Norway, 8 January 2026 - Lifecare ASA (LIFE) today announces a major system-level milestone, reporting the first in-vivo confirmatio...

MFN • 08 jan 07:00

Lifecare ASA: Mandatory notification of trade – allocation of subscription rights

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 7 January 2026, regarding the commencement...

MFN • 07 jan 09:44

Lifecare ASA: Commencement of the subscription period for the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 07 jan 07:00

Lifecare ASA: Approval and publication of prospectus for Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 06 jan 10:52

Lifecare ASA – CFO transition

MFN • 05 jan 22:38

Lifecare ASA – Ex. subscription rights today

Issuer name: Lifecare ASA

MFN • 05 jan 07:00

LIFECARE ASA: Minutes from Extraordinary General Meeting

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 2 January 2026.

MFN • 02 jan 16:55

Lifecare ASA: New share capital registered

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") on 12 November 2025 regarding the resolution by the Ext...

MFN • 31 dec 2025 10:40

Lifecare ASA: Updated key information relating to the proposed partially underwritten rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 30 dec 2025 19:05

Lifecare implants first consistently manufactured implant

Bergen, Norway, 16 December 2025 - Lifecare ASA (LIFE), a MedTech company developing next-generation implantable Continuous Glucose Monitori...

MFN • 16 dec 2025 07:00

LIFECARE ASA: Extraordinary General Meeting

Lifecare ASA, a MedTech company developing next-generation continuous glucose monitoring (CGM) technology, will hold an Extraordinary Genera...

MFN • 11 dec 2025 15:00

Lifecare receives preliminary assessment from NoMA in first-in-human study application

Bergen, Norway, 11 December 2025 - Lifecare ASA (LIFE), a MedTech company developing next generation Continuous Glucose Monitoring (CGM) tec...

MFN • 11 dec 2025 07:00

Minutes from Extraordinary General Meeting

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 12 November 2025.

MFN • 12 nov 2025 20:34

LIFE: Lifecare ASA Q3 2025 results

Bergen, Norway, 12 November 2025: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continu...

MFN • 12 nov 2025 07:00

Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results

Lifecare ASA will release its results for the third quarter of 2025 on Wednesday, 12 November 2025 at 07:00 a.

MFN • 06 nov 2025 07:00

Lifecare shares key learnings from ongoing longevity study LFC-SEN-002

Bergen, Norway, 5 November 2025 – Lifecare ASA (LIFE), a MedTech company developing next-generation implantable Continuous Glucose Monitorin...

MFN • 05 nov 2025 07:00

Lifecare receives update from NOMA on handling time for first-in-human study application

Bergen, Norway, 28 October 2025 – Lifecare ASA (LIFE), a MedTech company developing next generation Continuous Glucose Monitoring (CGM) tech...

MFN • 28 okt 2025 07:00

LIFECARE ASA: Extraordinary General Meeting

Lifecare ASA, a MedTech company developing next-generation continuous glucose monitoring (CGM) technology, will hold an Extraordinary Genera...

MFN • 22 okt 2025 14:00

Lifecare ASA: Key information relating to the proposed partially underwritten rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 22 okt 2025 07:16

Lifecare ASA: Proposed partially underwritten rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 22 okt 2025 07:15

Lifecare strengthens miniaturisation roadmap with new patent applications

Bergen, Norway, 24 September 2025 – Lifecare ASA (LIFE), a MedTech company developing next-generation continuous glucose monitoring (CGM) te...

MFN • 24 sep 2025 07:00

LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY

Bergen, Norway, 15 September 2025 – Lifecare ASA (LIFE), a MedTech company developing next generation of Continuous Glucose Monitoring (CGM)...

MFN • 15 sep 2025 07:00

Reconfirmed positive results in veterinary study support path toward market entry

Bergen, Norway, 27 August 2025 – Lifecare ASA (LIFE), a MedTech company developing next generation Continuous Glucose Monitoring (CGM) techn...

MFN • 27 aug 2025 07:00

LIFE: Lifecare ASA Q2 2025 results

Bergen, Norway, 20 August 2025: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuou...

MFN • 20 aug 2025 07:00

Lifecare advances CE mark preparation for its groundbreaking medical device

Bergen, Norway, 13 August 2025 – Lifecare ASA (LIFE), a MedTech company developing next-generation Continuous Glucose Monitoring (CGM) techn...

MFN • 13 aug 2025 07:47

Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST

Lifecare ASA will publish its Q2 2025 results on Wednesday, 20 August 2025, at 07:00 CEST.

MFN • 12 aug 2025 14:35

Lifecare receives ethics approval to initiate first-in-human trial in Norway

Bergen, Norway, 5 August 2025 – Lifecare ASA (LIFE), a MedTech company developing next-generation Continuous Glucose Monitoring (CGM) techno...

MFN • 05 aug 2025 07:00

Lifecare achieves full radio frequency compliance for CGM implant – clearing the way for CE mark of electronics

Bergen, Norway, 8 July 2025 – Lifecare ASA (LIFE), a MedTech company developing next-generation Continuous Glucose Monitoring (CGM) technolo...

MFN • 08 jul 2025 07:00

Lifecare advances electromagnetic compatibility compliance testing for CGM implant

Bergen, Norway, 1 July 2025 – Lifecare ASA (LIFE), a medtech company developing next-generation Continuous Glucose Monitoring (CGM) technolo...

MFN • 01 jul 2025 07:00

Lifecare ASA: Share capital increase registered

Reference is made to the stock exchange announcement made by Lifecare ASA (the "Company") on 13 June 2025 regarding the final results follow...

MFN • 25 jun 2025 14:10

Lifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue

Reference is made to the stock exchange announcement made by Lifecare ASA (the "Company") on 13 June 2025 regarding the last day of the exer...

MFN • 13 jun 2025 18:19

Lifecare ASA: Notification of trade - exercise of warrants

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") dated 2 June 2025 regarding the commencement of the exe...

MFN • 13 jun 2025 09:35

Lifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") on 2 June 2025 regarding the commencement of the exerci...

MFN • 13 jun 2025 07:00

Lifecare ASA: Notification of trade - exercise of warrants

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") dated 2 June 2025 regarding the commencement of the exe...

MFN • 12 jun 2025 10:12

Lifecare ASA: Notification of trade - exercise of warrants

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") dated 2 June 2025 regarding the commencement of the exe...

MFN • 12 jun 2025 10:11

Lifecare ASA: Notification of trade - exercise of warrants

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") dated 2 June 2025 regarding the commencement of the exe...

MFN • 06 jun 2025 10:37

Lifecare ASA: Last day of trading in the Warrants issued in connection with the Rights Issue

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") on 2 June 2025 regarding the commencement of the exerci...

MFN • 06 jun 2025 07:00

Lifecare ASA: Mandatory notification of trade - exercise of warrants

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") dated 2 June 2025 regarding the commencement of the exe...

MFN • 05 jun 2025 12:52

Lifecare ASA: Commencement of the Exercise Period for the Warrants issued in connection with the Rights Issue

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") on 2 June 2025 regarding the exercise price for the 4,1...

MFN • 02 jun 2025 07:10

Lifecare ASA: Exercise price for the Warrants issued in connection with the Right Issue

Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") on 14 June 2024 regarding the final results of the part...

MFN • 02 jun 2025 07:00

Lifecare announces second clinical trial site at Pfützner Science & Health Institute in Mainz, Germany

Bergen, Norway, 30 May 2025 – Lifecare ASA (LIFE), a medtech company developing next-generation Continuous Glucose Monitoring (CGM) technolo...

MFN • 30 maj 2025 07:00

Lifecare appoints renowned metabolic expert Prof. Simon Dankel as Principal Investigator for upcoming clinical trial

Bergen, Norway, 27 May 2025 – Lifecare ASA (LIFE), a medtech company developing next-generation Continuous Glucose Monitoring (CGM) technolo...

MFN • 27 maj 2025 07:00

Lifecare files for human clinical trial, paving the way for CE-mark

Bergen, Norway, 20 May 2025 – Lifecare ASA (LIFE), a medtech company developing next-generation Continuous Glucose Monitoring (CGM) solution...

MFN • 20 maj 2025 07:00

Lifecare ASA: Livestream strategic update

Bergen, Norway, 16 May 2025 - Lifecare ASA (LIFE), a medtech company developing next generation continuous glucose monitoring (CGM) solution...

MFN • 16 maj 2025 14:01

LIFE: Lifecare ASA Q1 2025

Bergen, Norway, 15 May 2025: Today, Lifecare ASA (LIFE), ("Lifecare" or the "Company"), a clinical stage medical sensor company developing t...

MFN • 15 maj 2025 07:00

Lifecare ASA (LIFE): Invitation to presentation of Q1 2025 results and strategic update

Lifecare ASA will release its results for the first quarter of 2025 on Thursday, 15 May 2025 at 07:00 a.

MFN • 09 maj 2025 07:00

Lifecare ASA: Updated company presentation

Bergen, Norway, 23 April 2025 - Lifecare ASA (LIFE), a medtech company developing next generation continuous glucose monitoring (CGM) soluti...

MFN • 23 apr 2025 07:00

Annual General Meeting

Lifecare ASA will hold a General Meeting on 24 April 2025, at 16:30 (CEST).

MFN • 03 apr 2025 13:25

LIFE: First positive indication of increased sensor sensitivity in ongoing longevity study

Bergen, Norway, 25 March – Lifecare ASA (LIFE), a medical sensor company advancing product development for the next-generation Continuous Gl...

MFN • 25 mar 2025 07:00

Lifecare scientific updates: CGM symposium in Bergen, consensus recommendations from the Diabetes Technology Society and presentation of data at ATTD 2025

Bergen, Norway, 20 March 2025 – Lifecare ASA (LIFE) is a medical sensor company advancing product development for the next-generation Contin...

MFN • 20 mar 2025 07:00

LIFE: Lifecare ASA Q4 2024

Bergen, Norway, 20 February 2025: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next ge...

MFN • 20 feb 2025 07:00

Lifecare ASA Q4 2024 presentation

Lifecare ASA will release its fourth quarter 2024 results on Thursday 20 February 2025 at 07:00 a.

MFN • 19 feb 2025 10:27

LIFE: Improved chemistry successfully tested in sensor

Bergen, Norway, 4 February 2025: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 04 feb 2025 07:00

LIFE – Fivefold improvement of sensor chemistry sensitivity

Bergen, Norway, 14 January 2025: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 14 jan 2025 07:00

LIFE: Lifecare ASA Q3 2024

Bergen, Norway, 13 November 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next ge...

MFN • 13 nov 2024 07:00

Lifecare ASA Q3 2024 presentation

Lifecare ASA will release its third quarter 2024 results on Wednesday 13 November 2024 at 07:00 a.

MFN • 05 nov 2024 10:40

Lifecare - Sanofi Product Development Agreement Update

Bergen, Norway, 29 October 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Gluc...

MFN • 29 okt 2024 07:00

Lifecare ASA listed on Euronext Oslo Børs

Bergen, Norway, 22 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 22 okt 2024 10:00

LIFE – Lifecare ASA uplisting to Euronext Oslo Børs is approved

Bergen, Norway, 21 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 21 okt 2024 17:27

Lifecare ASA: Share capital increase registered

Reference is made to the stock exchange announcement made by Lifecare ASA (the "Company") on 15 October 2024 regarding the successful result...

MFN • 18 okt 2024 10:59

Lifecare ASA: Public retail offering successfully placed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN O...

MFN • 15 okt 2024 23:05

Lifecare ASA: Last day of application period

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN O...

MFN • 15 okt 2024 07:00

Lifecare presentation at the Diabetes Technology Meeting 2024.

Bergen, Norway, October 14, 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glu...

MFN • 14 okt 2024 07:05

Lifecare ASA: Application deadline for applicants using Nordnet webservice

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN O...

MFN • 14 okt 2024 07:00

Lifecare ASA: Mandatory notification of trade

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 8 October 2024, regarding the commencement...

MFN • 10 okt 2024 15:10

LIFE – Study protocol has been finalized for submission to regulatory authorities

Bergen, Norway, 10 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 10 okt 2024 07:00

Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today

Reference is made to the stock exchange announcement made on 27 September 2024 with key information regarding the consolidation (reverse spl...

MFN • 01 okt 2024 07:00

Lifecare ASA: Share consolidation (reverse split) and change of par value

Reference is made to the extraordinary general meeting in Lifecare ASA (the "Company") held on 17 September 2024, where it was resolved to c...

MFN • 30 sep 2024 17:31

Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants and change of ISIN for the shares

Reference is made to the extraordinary general meeting of the Company held on 17 September 2024, where it was resolved to consolidate the Co...

MFN • 27 sep 2024 17:22

Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants

Reference is made to the extraordinary general meeting of the Company held on 17 September 2024, where it was resolved to consolidate the Co...

MFN • 26 sep 2024 07:00

Lifecare ASA: Re-purchase of shares and warrants completed

Reference is made to the stock exchange announcement made by Lifecare ASA (the "Company") earlier today, 25 September 2024, regarding the re...

MFN • 25 sep 2024 12:15

Lifecare ASA: Re-purchase of shares and warrants

Reference is made to the contemplated consolidation of shares in Lifecare ASA (the "Company") in a ratio of 13:1, as resolved by the extraor...

MFN • 25 sep 2024 07:00